17 August 2026 Current Affairs for UPSC, SSC, Bank & Railway

A landmark clinical study spanning three years has discovered that a widely prescribed blood pressure and hypertension medication can effectively treat Vanishing White Matter disease, a rare and potentially fatal genetic neurological disorder affecting children. Researchers found that the drug stabilizes cellular stress responses, offering the first viable therapeutic option to slow or halt progressive brain degeneration in pediatric patients across global medical trials. Vanishing White Matter disease is an extremely rare leucodystrophy caused by genetic mutations in the EIF2B gene complex, which is vital for cellular protein synthesis. The condition causes progressive destruction of the brain's white matter, leading to rapid loss of motor skills, intellectual impairment, seizures, and premature death. Until this discovery, no global regulatory agency had approved any effective medical therapy to slow disease progression. Key scientific insights from the study reveal that the hypertension drug targets the Integrated Stress Response pathway within brain cells, preventing premature cell death caused by mutated proteins. Because the medication already possesses established clinical safety profiles in human usage, repurposing this drug significantly reduces pharmaceutical development timelines, manufacturing costs, and clinical trial regulatory hurdles needed for full public approval. This scientific discovery is highly relevant for UPSC General Studies Paper Three under Science and Technology, covering biotechnology, genetic disorders, and pharmaceutical advancements. Candidates should prepare concepts related to genetic mutations, rare diseases policy in India, drug repurposing mechanisms, and the biological functioning of human central nervous system pathways for Prelims and Mains exams.

17 August 2026 Current Affairs for UPSC, SSC, Bank & Railway

Study finds common hypertension medication treats rare fatal brain disease VWM